Clinical trials
Thrombocytopenia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 2 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 7 |
| Not yet recruiting | 3 |
| Terminated | 3 |
| Unknown status | 3 |
| Withdrawn | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 2 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Northwestern University | 2 |
| Amgen | 1 |
| Anhui Provincial Cancer Hospital | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assiut University | 1 |
| Centre Hospitalier Annecy Genevois | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocytopenia | 39 |
| Anemia | 5 |
| Neutropenia | 4 |
| Hematologic Diseases | 3 |
| Hematologic Neoplasms | 3 |
| Hemostatic Disorders | 3 |
| Ischemic Stroke | 3 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Coronary Artery Disease | 2 |
| Hemorrhagic Stroke | 2 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.